147 related articles for article (PubMed ID: 28682926)
1. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
Aumente MD; López-Santamaría J; Donoso-Rengifo MC; Reyes-Torres I; Montejano Hervás P
Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay: Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
Bouquié R; Grégoire M; Hernando H; Azoulay C; Dailly E; Monteil-Ganière C; Pineau A; Deslandes G; Jolliet P
Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
[TBL] [Abstract][Full Text] [Related]
3. Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay.
Coentrão L; Carvalho C; Sampaio S; Oliveira JG; Pestana MI
Transplant Proc; 2010 Jun; 42(5):1867-9. PubMed ID: 20620539
[TBL] [Abstract][Full Text] [Related]
4. Using fluorescence polarization immunoassay for determination of erythrocyte methotrexate polyglutamates, a quick and easy test?
den Boer E; Koch BC; Huisman R; de Jonge R
Ther Drug Monit; 2014 Dec; 36(6):819-23. PubMed ID: 24739667
[TBL] [Abstract][Full Text] [Related]
5. Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.
Borgman MP; Hiemer MF; Molinelli AR; Ritchie JC; Jortani SA
Ther Drug Monit; 2012 Apr; 34(2):193-7. PubMed ID: 22377747
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Simple and Rapid UPLC-MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods.
Zhao M; Li G; Qiu F; Sun Y; Xu Y; Zhao L
Ther Drug Monit; 2016 Apr; 38(2):246-52. PubMed ID: 26488205
[TBL] [Abstract][Full Text] [Related]
7. Comparison of four immunoassays to an HPLC method for the therapeutic drug monitoring of methotrexate: Influence of the hydroxylated metabolite levels and impact on clinical threshold.
Descoeur J; Dupuy AM; Bargnoux AS; Cristol JP; Mathieu O
J Oncol Pharm Pract; 2022 Jan; 28(1):55-63. PubMed ID: 33427019
[TBL] [Abstract][Full Text] [Related]
8. [Serum monitoring of methotrexate (MTX) and 7-hydroxymethotrexate concentrations in patients treated with MTX using high-pressure liquid chromatography (HPLC) and comparison of serum MTX levels between HPLC method and fluorescence polarization immunoassay (FPIA)].
Sakamoto S; Matsuhisa T; Miyoshi K; Naruse R; Urayama H; Shimokawa T; Okabe K; Toki H; Motoi M; Moriwaki S
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1119-25. PubMed ID: 2053771
[TBL] [Abstract][Full Text] [Related]
9. UPLC-MS/MS Analysis of Methotrexate in Human Plasma and Comparison with the Fluorescence Polarization Immunoassay.
Mei S; Zhu L; Li X; Wang J; Jiang X; Chen H; Huo J; Yang L; Lin S; Zhao Z
Anal Sci; 2017; 33(6):665-670. PubMed ID: 28603183
[TBL] [Abstract][Full Text] [Related]
10. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
Günther V; Mueller D; von Eckardstein A; Saleh L
Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of teicoplanin concentrations in human plasma.
Dailly E; Fraissinet F; Deslandes G; Bouquié R; Jolliet P
J Clin Lab Anal; 2013 Mar; 27(2):96-8. PubMed ID: 23378010
[TBL] [Abstract][Full Text] [Related]
12. Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.
Wu XJ; Zhang J; Yu JC; Cao GY; Shi YG; Zhang YY; Wang MG
J Antibiot (Tokyo); 2012 Jan; 65(1):35-9. PubMed ID: 22045420
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum digoxin concentration monitoring by fluorescence polarization immunoassay on the TDxFLx and dry chemistry enzyme immunoassay on the Vitros 950.
Solnica B
Clin Chem Lab Med; 2004; 42(8):958-64. PubMed ID: 15387450
[TBL] [Abstract][Full Text] [Related]
14. Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population.
Guerriero E; Simon N; Nelken B; Baldeyrou B; Djobo B; Vasseur M; Allorge D; Décaudin B; Odou P
Ther Drug Monit; 2014 Aug; 36(4):499-504. PubMed ID: 25014075
[TBL] [Abstract][Full Text] [Related]
15. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system.
Mendu DR; Chou PP; Soldin SJ
Ther Drug Monit; 2007 Oct; 29(5):632-7. PubMed ID: 17898655
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a Novel Immunoassay for Lacosamide Therapeutic Drug Monitoring: Comparison With a Liquid Chromatography-Mass Spectrometry Assay.
DʼUrso A; Ricotta T; de Grazia U
Ther Drug Monit; 2017 Dec; 39(6):663-668. PubMed ID: 29135908
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
[TBL] [Abstract][Full Text] [Related]
18. Analytical interference in the therapeutic drug monitoring of methotrexate.
Oudart JB; Marquet B; Feliu C; Gozalo C; Djerada Z; Millart H
Ann Biol Clin (Paris); 2016 Jun; 74(3):333-7. PubMed ID: 27101631
[TBL] [Abstract][Full Text] [Related]
19. The influence of 7-OH methotrexate metabolite on clinical relevance of methotrexate determination.
Klapkova E; Kukacka J; Kotaska K; Suchanska I; Urinovska R; Prusa R
Clin Lab; 2011; 57(7-8):599-606. PubMed ID: 21888024
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte methotrexate-polyglutamate assay using fluorescence polarization immunoassay technique: application to the monitoring of patients with rheumatoid arthritis.
Inoue S; Hashiguchi M; Kawai S; Mochizuki M
Yakugaku Zasshi; 2009 Aug; 129(8):1001-5. PubMed ID: 19652507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
